Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Li S, Silvestri V, Leslie G, Rebbeck TR, et al. J Clin Oncol 2022;40:1529-1541.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li S, Silvestri V, Leslie G, Rebbeck TR, et al. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J Clin Oncol 2022;40:1529-1541.
PMID: 35077220